Observations placeholder
Meridia
Identifier
019513
Type of Spiritual Experience
Background
A description of the experience
Sibutramine (usually in the form of the hydrochloride monohydrate salt) is an oral anorexiant. Until 2010 it was marketed and prescribed as an adjunct in the treatment of exogenous obesity along with diet and exercise. It has been associated with increased cardiovascular events and strokes and has been withdrawn from the market in several countries and regions
On Jan, 6, 2016: 6,725 people reported to have side effects when taking Meridia. Among them, 17 people (0.25%) have Hallucination.
Time on Meridia when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 50.00% | 25.00% | 0.00% | 25.00% | 0.00% | 0.00% | 0.00% |
On Jan, 6, 2016: 6,725 people reported to have side effects when taking Meridia. Among them, 28 people (0.42%) have Death.
Time on Meridia when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 16.67% | 16.67% | 50.00% | 16.67% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Meridia :
Female | Male | |
Death | 76.00% | 24.00% |